Navigation auf


Life Science Zurich Communication & Events

Attack on chemotherapy-resistant leukemia cells

Childhood cancer: targeted therapy of resistant leukemia cells (Image: Gabriela Acklin, Children’s Hospital Zurich)

Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer in Switzerland. Despite intensive chemotherapy, one fifth of the patients suffer a relapse, which usually goes hand in hand with a poor prognosis. Researchers from the University of Zurich and the Children’s Hospital Zurich have now found a way to kill off resistant leukemia cells: via necroptosis.

UZH News release